Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMID 16443060)

Published in J Am Acad Dermatol on February 01, 2006

Authors

Catherine A Harwood1, Charlotte M Proby, Jane M McGregor, Michael T Sheaff, Irene M Leigh, Rino Cerio

Author Affiliations

1: Centre for Cutaneous Research, Institute for Cell and Molecular Science, Bart's and the London Queen Mary's School of Medicine and Dentistry, University of London, London, United Kingdom. caharwood@doctors.org.uk

Articles by these authors

Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2008) 3.34

Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A (2011) 3.10

Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science (2005) 2.31

Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. J Clin Oncol (2013) 2.29

Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet (2005) 1.97

Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol (2004) 1.95

Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. J Cell Biol (2002) 1.83

Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol (2002) 1.66

Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res (2005) 1.59

Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol (2007) 1.57

Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells. J Invest Dermatol (2011) 1.44

Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer (2007) 1.39

Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol (2005) 1.38

Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One (2013) 1.32

Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res (2010) 1.30

The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol (2005) 1.29

Extramedullary hematopoiesis in the endometrium. Int J Gynecol Pathol (2002) 1.26

RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet (2012) 1.18

Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. J Cell Sci (2003) 1.16

Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis (2002) 1.16

Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol (2006) 1.15

Treatment of pachyonychia congenita. J Investig Dermatol Symp Proc (2005) 1.13

Early death from cardiomyopathy in a family with autosomal dominant striate palmoplantar keratoderma and woolly hair associated with a novel insertion mutation in desmoplakin. J Invest Dermatol (2006) 1.12

Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol (2005) 1.11

The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms. PLoS One (2009) 1.09

Tyrosine dephosphorylation is required for Bak activation in apoptosis. EMBO J (2010) 1.09

Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs. J Invest Dermatol (2009) 1.08

p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol (2004) 1.08

High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol (2003) 1.07

Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res (2012) 1.07

Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn (2005) 1.07

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer (2008) 1.06

Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase. J Clin Oncol (2013) 1.06

Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci (2007) 1.04

Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol (2009) 1.04

The keratins and their disorders. Am J Med Genet C Semin Med Genet (2004) 1.01

Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab Emirates. Hum Genet (2002) 1.00

Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol (2005) 0.99

HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. Exp Dermatol (2007) 0.97

Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol (2007) 0.97

Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene. Hum Genet (2004) 0.96

A comparison of tissue-engineered hyaluronic acid dermal matrices in a human wound model. Tissue Eng (2006) 0.96

Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol (2011) 0.96

Palisaded neutrophilic granulomatous dermatitis associated with systemic lupus erythematosus presenting with the burning rope sign. J Am Acad Dermatol (2009) 0.95

Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. Int J Cancer (2011) 0.95

Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types. J Clin Microbiol (2010) 0.94

Clinical and genetic heterogeneity of erythrokeratoderma variabilis. J Invest Dermatol (2005) 0.94

Mutations in AQP5, encoding a water-channel protein, cause autosomal-dominant diffuse nonepidermolytic palmoplantar keratoderma. Am J Hum Genet (2013) 0.94

Epidermal repair results from activation of follicular and epidermal progenitor keratinocytes mediated by a growth factor cascade. Wound Repair Regen (2007) 0.93

ARNT controls the expression of epidermal differentiation genes through HDAC- and EGFR-dependent pathways. J Cell Sci (2012) 0.92

Two mechanisms regulate keratin K15 expression in keratinocytes: role of PKC/AP-1 and FOXM1 mediated signalling. PLoS One (2012) 0.91

An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity. J Oral Pathol Med (2008) 0.91

Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus. Oncogene (2002) 0.89

Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. Lung Cancer (2005) 0.89

Defective trafficking and cell death is characteristic of skin disease-associated connexin 31 mutations. Hum Mol Genet (2002) 0.88

Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients. J Med Virol (2012) 0.86

Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulfate proteoglycan core protein. J Invest Dermatol (2004) 0.86

Functional studies of human skin disease- and deafness-associated connexin 30 mutations. Biochem Biophys Res Commun (2002) 0.86

Influence of evaluation of clinical pictures on the histopathologic diagnosis of inflammatory skin disorders. J Am Acad Dermatol (2010) 0.86

Adducin expression in cutaneous and oral lesions: alpha- and beta-adducin transcripts down-regulate with keratinocyte differentiation in stratified epithelia. J Pathol (2003) 0.86

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis. J Exp Med (2013) 0.85

Expression of keratin K2e in cutaneous and oral lesions: association with keratinocyte activation, proliferation, and keratinization. Am J Pathol (2003) 0.85

Prospective study of sentinel lymph node biopsy for conjunctival melanoma. Br J Ophthalmol (2013) 0.84

Benign cephalic histiocytosis in a British-African child. Pediatr Dermatol (2005) 0.84

Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol (2005) 0.84

Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim Biophys Acta (2010) 0.83

Cellular mechanisms of mutant connexins in skin disease and hearing loss. Cell Commun Adhes (2003) 0.83

Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members. J Invest Dermatol (2010) 0.82

Carcinogenic mechanisms related to immunosuppressive therapy. Cancer Treat Res (2009) 0.81

Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken) (2014) 0.81

Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol (2012) 0.81

The role of allogenic fibroblasts in an acute wound healing model. Plast Reconstr Surg (2004) 0.80

Autoimmune subepidermal bullous skin diseases: the impact of recent findings for the dermatopathologist. Virchows Arch (2003) 0.80

A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis. Int J Dermatol (2015) 0.80

Appendageal malignancies. Cancer Treat Res (2009) 0.79

Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma. Cancer (2007) 0.78

Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients. Virology (2012) 0.78

Cutaneous mucinous carcinoma arising in extramammary Paget disease of the perineum. Am J Dermatopathol (2011) 0.78

The reduction of water-soluble tetrazolium salt reagent on the plasma membrane of epidermal keratinocytes is oxygen dependent. Anal Biochem (2011) 0.77

A protective effect of glutathione-S-transferase GSTP1*Val(105) against polymorphic light eruption. J Invest Dermatol (2008) 0.77

Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes. J Cell Sci (2013) 0.76

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer. Int J Cancer (2007) 0.76

The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol (2016) 0.76